Literature DB >> 2492207

Prostaglandin H synthase-dependent mutagenic activation of benzidine in a Salmonella typhimurium Ames tester strain possessing elevated N-acetyltransferase levels.

P D Josephy1, A L Chiu, T E Eling.   

Abstract

Watanabe and colleagues (Biochem. Biophys. Res. Commun. 147: 974-979, 1987) have constructed plasmid-containing derivatives of Salmonella typhimurium Ames tester strain TA1538 with high levels of acetyltransferase activities. In this paper, we describe the mutagenic response of one of these strains, TA1538/1,8-DNP6 (pYG 121), to the bladder carcinogen benzidine and other arylamines. Strain TA1538/1,8-DNP6 (pYG 121) was far more sensitive to benzidine than any previous tester strain, following metabolism of the aromatic amine by hamster hepatic S9, ram seminal vesicle microsomal preparation (RSVM), or purified prostaglandin synthase. Therefore, bacterial acetyltransferase-dependent metabolism of a proximate mutagen is implicated in each of these systems. The mechanism of RSVM-dependent activation of benzidine was examined further. The arachidonic acid-independence and indomethacin insensitivity previously noted with strain TA98 were also observed with the new tester strain. We confirmed that prostaglandin H synthase is the enzyme activity responsible for activation of benzidine by RSVM. Purified prostaglandin H synthase holoenzyme, or apoenzyme reconstituted with heme, supported benzidine activation. However, apoenzyme reconstituted with manganese protoporphyrin IX, which yields enzyme having cyclooxygenase activity but not peroxidase activity, was inactive. Addition of catalase inhibited, and addition of exogenous hydrogen peroxide increased, RSVM-mediated benzidine mutagenicity. We propose that hydrogen peroxide released by the tester strain bacteria (rather than arachidonic acid-derived peroxide) is the oxidizing agent which supports prostaglandin H synthase peroxidase activity in Ames test systems.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2492207

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

Review 1.  Targeting the eicosanoid pathway in non-small-cell lung cancer.

Authors:  Leora Horn; Michael Backlund; David H Johnson
Journal:  Expert Opin Ther Targets       Date:  2009-05-02       Impact factor: 6.902

2.  Effect of low-dose aspirin use on pancreatic cancer development and morphological changes on imaging in IPMN: A long-term cohort study.

Authors:  Yusuke Takasaki; Naoyoshi Nagata; Koh Imbe; Yuya Hisada; Katsunori Sekine; Tsuyoshi Tajima; Mikio Yanase; Kazuma Fujimoto; Junichi Akiyama; Naomi Uemura
Journal:  United European Gastroenterol J       Date:  2017-02-05       Impact factor: 4.623

Review 3.  Non-coding RNAs and potential therapeutic targeting in cancer.

Authors:  Shusuke Toden; Timothy J Zumwalt; Ajay Goel
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-12-13       Impact factor: 10.680

Review 4.  N-hydroxyarylamine O-acetyltransferase of Salmonella typhimurium: proposal for a common catalytic mechanism of arylamine acetyltransferase enzymes.

Authors:  M Watanabe; T Igarashi; T Kaminuma; T Sofuni; T Nohmi
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.